An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|2|372-380

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.2, 2015-02, pp. : 372-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Factors for Major Adverse Events Late after Fontan Palliation

By  

CONGENITAL HEART DISEASE, Vol. 10, Iss. 2, 2015-03 ,pp. : 159-168

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating Adiponectin: Associations with Risk Factors and the Reynolds Risk Score in Women without Prior Major Cardiovascular Events

By  

Cardiology, Vol. 115, Iss. 1, 2009-10 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Clinical Risk Factors for In‐hospital Adverse Cardiovascular Events After Acute Drug Overdose

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 5, 2015-05 ,pp. : 499-507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Echocardiography Predicts Major Adverse Cardiovascular Events after Renal Transplantation

By  

Nephron Clin Pract, Vol. 126, Iss. 1, 2014-03 ,pp. : 75-80

Karger

Access to resources Recommend Favorite

Low testosterone and sexual symptoms in men with acute coronary syndrome can be used to predict major adverse cardiovascular events during long‐term follow‐up

By  

ANDROLOGY, Vol. 3, Iss. 6, 2015-11 ,pp. : 1113-1118

John Wiley & Sons Inc

Access to resources Recommend Favorite